Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 20, 2022 3:33pm
RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
,,,,,Hummmm........just a thought,,,,, but,,,,if there is leakage of a Lazarus effect,,,,I think we will have a chance of seeing the CUP being requested!,,,,that would be a great indication to the
...more
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 20, 2022 5:37am
RE:RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
Hummmmm,,welll,,its been 48 hours since we were first notified dosing had started with trial patients,,,,,I will assume the johnny shirts are off and the street clothes are on those not on placebo!!!&
...more
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 19, 2022 8:26am
RE:RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
Purdy well on the mark sj1,,,,,,,however if they accidentally do get good numbers in any form we might get a bump up in share price........I see a few media outlets have picked up the C19 dosing story
...more
(3)
•••
seanj1
X
View Profile
View Bullboard History
Comment by
seanj1
on Jan 19, 2022 2:19am
RE:Commencement of Patient Enrollment/Dosing in Phase 2b trial
They are going to mess up the study... as long as McCaffrey is in charge, market will not trust the company and what it says. Hence the sp lack of action..
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 18, 2022 6:45pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Interference
GV,,,,,,lets hope is right,,,,,,the market is not putting any speculation into this company because of its inability to prove and provide sharevalue these past 20 years. Nothing will move the share
...more
(91)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 18, 2022 12:30pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Interference
narmac, let's hope this is not another false start for the open-label Phase 2b study of Apabetalone in Covid infection. Got my fingers crossed. All the best G1945V
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 18, 2022 11:32am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Interference
Ottawa is busy attepting to negotiate oral pills from Merck and Pfizer!!,, JT will blow his load with BP. Probably little to nothing will be left for a lethargic no namer like RVX. Especially with our
...more
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 18, 2022 9:19am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Interference
If Eversana can get it on major news networsk, that will 100% light a fire under the stock.....!!
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 18, 2022 9:12am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Interference
Couldn't agree more. Am very interested to see if Eversana will be able to get this news on any Canadian channels tonight.
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 18, 2022 9:09am
RE:RE:RE:RE:RE:RE:RE:RE:Interference
QT If the initial results are good, with the FDA BTD, lets hope RVX gets a Emergency use authorization, that will get things moving
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 18, 2022 7:51am
RE:RE:RE:RE:RE:RE:RE:Interference
We've got liftoff, Priceless!!!!! Best of luck to all that have stuck it out this long.
(2879)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jan 18, 2022 7:23am
Commencement of Patient Enrollment/Dosing in Phase 2b trial
CALGARY, Alberta, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today that enrollment and dosing of patients has commenced in a Phase
...more
(33)
•••
toinv261
X
View Profile
View Bullboard History
Comment by
toinv261
on Jan 17, 2022 11:42am
RE:Brown envelopes
geric, IMHO Don hasn't been booted for the following reasons; Don controls the 3 most powerful positions - COB, CEO and president. The 2 directors who are protecting their wealth, Hepa
...more
(63)
•••
geric
X
View Profile
View Bullboard History
Post by
geric
on Jan 17, 2022 10:58am
Paxlovid
Health Canada approval today for Paxlovid.
(28)
•••
priceless
X
View Profile
View Bullboard History
Comment by
priceless
on Jan 17, 2022 10:28am
RE:RE:RE:RE:RE:RE:Interference
QT, yes I listened to the Dec webcast and CC, and someone on the RVX Covid cliical advisory team has been on CNN numerous times in the past few year. IMO RVX needs a BP partnership
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >